Biotech entity
clinical-trial is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention American Association for Cancer Research (AACR), the most common co-covered peer. National Cancer Institute (NCI) appears in 1 tracked Biotech story from July 15, 2026.
Last mentioned: Jul 15, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
clinical-trial is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention American Association for Cancer Research (AACR), the most common co-covered peer. National Cancer Institute (NCI) appears in 1 tracked Biotech story from July 15, 2026. The tracked stories average 9 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering National Cancer Institute (NCI). Shared-story counts are live from our verified record — not editorial picks.
AACR Report Released
The American Association for Cancer Research publishes its report on cancer disparities research disruption, revealing 93% of surveyed researchers affected.
JAMA Oncology Publication
A study in JAMA Oncology details the cancellation of 181 NCI grants, bringing the issue to wider academic attention.
NCI Cancels 181 Grants
In the first half of 2025, the National Cancer Institute cancels 181 grants worth over $317 million, many focused on cancer disparities research.
Executive Order on Federal Grants
The Trump administration issues an executive order enabling freezes and cancellations of scientific research grants, particularly those related to diversity and equity.
The cancellation of 181 NCI grants totaling $317 million in early 2025 has stopped cancer disparity clinical trials in their tracks, according to an AACR report. The biotech and pharma pipelines face disruption as critical early-stage research evaporates.
Source: houstonpublicmedia.org · wyomingpublicmedia.org
National Cancer Institute (NCI) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
